Page results
-
This page provides information about the multidisciplinary Huntington’s Disease Clinic, which is held twice a month at the NHNN.
-
This Huntington’s disease service page provides information on Advance Care Planning: it gives patients and their loved ones the opportunity to talk about and document their wishes, preferences and priorities as the disease progresses.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
The purpose of this page is to explain what an ectopic pregnancy is, what it means for your health, the different treatment options, risks involved in treatment, and potential risks in future pregnancies.
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Patient information for patients who have been recommended to use a Mepilex® dressing on their skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Patient information for patients who have been recommended to use a Polymem® dressing on your skin that has broken down due to radiotherapy or proton beam therapy treatment.
File results
-
FOI/2022/0551 - Procurement contact details
-
FOI/2022/0555 - Senior staff contact details
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0542 - Infection control audits from September 2020 to April 2021
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0559 - Proton Beam Therapy contract
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology